Mirabegron: a guide to its use in overactive bladder syndrome in the EU Mark SanfordKatherine A. Lyseng-Williamson Adis Drug Clinical Q&A 12 March 2015 Pages: 107 - 111
Fluticasone furoate/vilanterol dry-powder inhaler: a guide to its use in chronic obstructive pulmonary disease Kate McKeage Adis Drug Clinical Q&A 20 February 2015 Pages: 112 - 117
Although pharmacological treatment may have beneficial effects in central post-stroke pain, it does not abolish the symptoms Adis Medical Writers Disease Management 04 February 2015 Pages: 118 - 121
Although diagnosis may be challenging, bullous systemic lupus erythematosus can be effectively managed with the limited therapies available Adis Medical Writers Disease Management 17 February 2015 Pages: 122 - 125
First reports of adverse drug reactions in recent weeks Adis Medical Writers Drug Reactions and Interactions 14 March 2015 Pages: 126 - 127
Preventative measures and prompt recognition are vital when managing dermatological toxicities associated with targeted cancer therapies Adis Medical Writers Drug Reactions and Interactions 18 February 2015 Pages: 128 - 132
Some nutritional supplements may have modest beneficial effects on lipid levels, but the effects of most are negligible Adis Medical Writers Practical Issues and Updates 04 March 2015 Pages: 133 - 136